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Introduction
Hemangioblastomas are rare benign vascular tumors of 
the central nervous system (CNS) and are composed of 
endothelial cells, pericytes, mast cells, and stromal cells. 
They account for 2.5% of all intracranial tumors and 8% 
to 12% of all posterior fossa tumors.1-3 In about 80% of 
patients the tumor is a sporadic, single lesion of the brain-
stem, upper cervical spinal cord, or cerebellum.4 The high-
est incidence is in young adults, with a slight male 
predominance. Approximately 20% of patients with intra-
cranial hemangioblastomas have Von Hippel–Lindau dis-
ease.5 Hemangioblastomas have also been reported outside 
the CNS, for example, in peripheral nerves,6,7 liver,8,9 
lung,10 pancreas,1 retroperitoneum,10 kidney,3,11-13 pan-
creas,11 urinary bladder,11 soft tissues of the ankle and 
popliteal fossa,13,14 and nasal skin.15 We present the first 
documented case of hemangioblastoma located in the left 
colon.
Case Report
In May 2009, a 75-year-old woman undergoing adjuvant 
chemotherapy for breast cancer (pT2, pN2a M0) at our 
institute experienced rectal bleeding, which led to signifi-
cant anemia (Hb = 7.8 g/dL). Colonoscopy was per-
formed, revealing a roundish mass covered with normal 
mucosa in the sigmoid colon (Figure 1A); the remaining 
gastrointestinal tract was normal. Biopsy of the lesion 
revealed normal histology. The bleeding was treated by 
endoscopic instillation of adrenaline. Endoscopic ultra-
sound (EUS) was performed using a 12-MHz miniprobe, 
revealing an isoechoic lesion of 14 mm × 11 mm with 
homogeneous echotexture originating from the third layer 
of the intestinal wall (submucosa; Figure 1B); the underly-
ing layers were normal. As EUS imaging was not strongly 
suggestive of either colon cancer or a malignant gastroin-
testinal stromal tumor, close monitoring was recommended. 
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Abstract
We present the first documented case of hemangioblastoma located in the left colon. A 75-year-old woman undergoing 
adjuvant chemotherapy for breast cancer experienced rectal bleeding. Colonoscopy revealed a roundish mass covered with 
normal mucosa in the sigmoid colon. Endoscopic ultrasound showed an isoechoic lesion originating from the third layer of the 
intestinal wall; underlying layers were normal. Endoscopic ultrasound features were not suggestive of either cancer or malignant 
stromal tumor. Left hemicolectomy was subsequently performed due to repeated episodes of lower gastrointestinal bleeding. 
Grossly, a circumscribed submucosal yellowish nodule (13 mm) was observed, which was not attached to any peripheral nerve. 
Histologically, the lesion was composed of large, atypical cells traversed by a network of blood vessels. Immunohistochemically, 
the cells showed positivity for inhibin and NSE and weak positivity for S-100. A diagnosis of hemangioblastoma was made. This 
case highlights that hemangioblastoma of the gastrointestinal tract can also occur.
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Figure 1.  A) Colonoscopy showing a roundish mass covered with normal mucosa in the sigmoid colon. B) Endoscopic ultrasound 
showing an isoechoic lesion. C) CT scan without contrast showing hypodense lesion. D) After contrast infusion, the lesion appeared 
hyperdense. E) Vascularization of the inferior mesenteric artery. F) Outflow from the superior mesenteric artery.
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At the 6-month follow-up, both endoscopy and EUS 
imaging was unchanged. A computed tomography (CT) 
scan performed without contrast revealed a hypodense 
lesion (Figure1C); after contrast infusion the lesion 
appeared hyperdense (Figure 1D). Vascularization of the 
inferior mesenteric artery was visible (Figure 1E), as was 
the outflow from the superior mesenteric artery (Figure 
1F). Following repeated episodes of lower gastrointestinal 
bleeding, the patient underwent left hemicolectomy in 
October 2010.
Macroscopic Features
The tumor (13 mm × 11 mm) was localized in the submu-
cosal layer of the large bowel and was well demarcated 
from the surrounding fibroadipose tissue. The cut section 
of the tumor was solid and yellow, with no evidence of 
necrosis or hemorrhage. The lesion was not associated 
with any visible nerves.
Microscopic Features
The tumor consisted of sheets of variously sized polygonal, 
epithelioid cells with eosinophilic cytoplasm and irregular, 
pleomorphic nuclei (Figure 2A and B). There was a sub-
population of tumor cells with bizarre nuclei and micro-
vacuolated cytoplasm, indicating the presence of lipids. A 
very prominent branching thin-walled vascular network 
was present. A number of vessels were ectasic, showing a 
hemangiopericytomatous pattern (Figure 2C). Mitotic fig-
ures were rare. There was no evidence of necrosis.
Immunohistochemical Findings
Slides for immunohistochemical staining were prepared 
from formalin-fixed, paraffin-embedded tissue. Staining 
was carried out using Bond-Max automated immunos-
tainer with heat-induced antigen retrieval and a polymer-
based immunohistochemical detection system. The 
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Figure 2.  A-C) Microscopic features of the lesion. D) Neoplastic cells strongly positive for inhibin. E) Neoplastic cells strongly 
positive for neuron-specific enolase. F) Neoplastic cells negative for pan-cytokeratin. G) Neoplastic cells negative for c-kit. H) 
Neoplastic cells negative for muscle-specific actin. I) Immunostaining for CD34 highlighted an abundance of non neoplastic vessels.
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neoplastic cells were strongly and diffusely positive for 
α-inhibin (Figure 2D) and neuron-specific enolase (Figure 
2E). Positivity for S100 protein was weak and multifocal. 
The tumor was negative for pan-cytokeratin (Figure 2F), 
c-kit (Figure 2G), DOG1, HMB45, muscle-specific actin 
(Figure 2H), desmin, chromogranin, and synaptophysin. 
Immunostaining for CD34 highlighted an abundance of 
nonneoplastic vessels (Figure 2I). A diagnosis of intestinal 
hemangioblastoma was made. On the basis of the histo-
logical findings, it was decided not administer adjuvant 
chemotherapy or radiotherapy. Almost 3 years have 
passed since surgery and the patient is disease-free and in 
good clinical condition.
Discussion
As far as we know, ours is the first reported case of 
hemangioblastoma of the gastrointestinal tract. CT and 
EUS imaging did not facilitate diagnosis, which ulti-
mately was based on the presence of typical morphology 
and immunophenotype. The recognition of hemangio-
blastoma depends, to a large extent, on awareness of the 
existence of such tumors. However, its occurrence in 
extraneural sites is so rare that such a hypothesis may not 
even be included in the differential diagnosis, which 
takes into account lipogenic tumors, melanoma, meta-
static clear cell carcinoma, gastrointestinal stromal 
tumor, capillary hemangioma, and paraganglioma. Large, 
multivacuolated cells of hemangioblastoma are similar 
to lipogenic cells.
Well-differentiated liposarcoma is normally paucivas-
cular, in contrast to the hemangioblastoma of our patient, 
which was not surrounded by areas of adipose tissue. 
Multivacuolated cells with centrally located vesicular 
nuclei and a rich capillary network are typical of hiber-
noma, but hibernoma cells do not show the pronounced 
nuclear atypia of our case. However, the strong positivity 
for α-inhibin16 helped in formulating the differential diag-
nosis. We also took the possibility of melanoma into con-
sideration as an in situ melanoma had been removed from 
the patient’s leg in October 2007, but this was rejected as 
tumor dimensions remained unchanged for almost 2 years 
and mitoses were rare in the biopsy specimen. Furthermore, 
HMB45 was completely negative. From a morphological 
point of view, differential diagnosis of hemangioblastoma 
includes metastatic carcinoma, in particular renal clear cell 
carcinoma and adrenocortical carcinoma. Taking into 
account the patient’s breast cancer history, it was also nec-
essary to rule out metastatic lobular carcinoma of the 
breast. The absence of pancytokeratin, cytokeratin 7, and 
HMB45 and the expression of S-100 and α-inhibin 
excluded the hypothesis of carcinoma. In view of the ana-
tomical location of the lesion, we also included gastroin-
testinal stromal tumor in the differential diagnosis, but 
immunohistochemistry for DOG1 and c-kit was com-
pletely negative. Like CNS hemangioblastomas, our 
patient’s tumor was characterized by prominent vascular 
proliferation, but the presence of peculiar stromal cells led 
to the exclusion of hemangioma or hemangiopericytoma. 
The lesion also had a very prominent network of thin-
walled branching blood vessels similar to that of paragan-
glioma but lacked its typical nested architecture.
Given the rarity of this tumor and the patient’s history 
of breast cancer and melanoma, genetic counseling was 
also performed because hemangioblastoma sporadically 
occurs in association with Von Hippel–Lindau disease. 
The patient’s professional activity had not exposed her to 
specific occupational carcinogens. The genealogical tree 
did not reveal a family history or any other clinical mani-
festation of the syndrome. Molecular genetic analysis, a 
more specific instrument to confirm or exclude Von 
Hippel–Lindau disease, was offered to the patient, but was 
refused.
Cerebral hemangioblastomas frequently exhibit overex-
pression of erythropoietin, which manifests as an increase 
in hemoglobin and of hematocrit values. This was not seen 
in our patient because of the numerous episodes of rectal 
bleeding. Furthermore, hemangioblastomas are benign but 
our case showed a marked nuclear atypia, which is unusual 
for this tumor. It was thus decided to monitor the patient 
closely with an annual CT scan and biannual clinical fol-
low-up with full blood counts. Colonoscopy was performed 
1 year after surgery and will be repeated at 3 and 5 years. 
Given the small dimensions of the tumor and the negative 
resection margins, it was decided not to administer chemo-
therapy or adjuvant radiotherapy.
The identification of hemangioblastoma depends, to a 
large extent, on both the clinical manifestation of the dis-
ease and radiological images. Surgery is performed and 
diagnosis is confirmed by histological examination. Because 
of its rarity, hemangioblastoma was not included in the dif-
ferential diagnosis of our patient by either the clinicians 
(oncologist and gastroenterologist) or radiologist involved. 
Immunohistochemical results (coexpression of α-inhibin, 
NSE, and S100), together with salient histological features 
(vacuolated epithelioid cells associated with a prominent 
vascular component), are other elements required for a cor-
rect diagnosis.
In conclusion, our experience shows that hemangioblas-
toma can also occur in the gastrointestinal tract, indicating 
that such a hypothesis should be taken into consideration in 
the differential diagnosis of similar clinical cases.
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